PHARMACY

NACDS RxImpact Day highlights patient, pharmacy advocacy issues

Pharmacy advocates from all 50 states reached every congressional office during NACDS RxImpact Day.
Lupin gets FDA nod for generic Lipitor

The FDA has approved Lupin's generic Lipitor tablets, which had a market value of roughly $696 million.
Tabula Rasa HealthCare acquires PrescribeWellness in $150 million deal

Tabula Rasa HealthCare is buying PrescribeWellness, which will continue to be led by CEO Al Babbington following the acquisition.
Cardinal Health taps Nielsen as U.S. retail analytics provider

Nielsen will provide retail market data for Cardinal Health and support its network of independent retail pharmacy partners.
Janssen gets FDA nod for Spravato

The approval of Spravato nasal spray to help tackle treatment-resistant depression marks the first time the FDA has approved its active ingredient, esketamine, for any use.
OptumRx receives PBMI's 2019 Excellence Award for opioid management strategies

OptumRx launched its opioid risk management program in July 2017.
FDA clears Wockhardt’s generic Zytiga

Wockhardt has received the FDA's nod for generic Zytiga, which has a market value of $1.6 billion.
Glenmark gets FDA nod for generic Micardis

The Food and Drug Administration has approved Glenmark's generic Micardis, which had a market value of roughly $40.6 million for the 12-month period ended January 2019.